Association of candidate genes (ALR2, RAGE, and VEGF) polymorphisms with diabetic retinopathy in type 2 diabetic patients of Khyber Pakhtunkhwa, Pakistan
- 1 November 2022
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (1) , 227-234
Abstract
No abstract availableKeywords
All Related Versions
This publication has 25 references indexed in Scilit:
- Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic RetinopathyCellular Physiology and Biochemistry, 2018
- Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stressLife Sciences, 2018
- Prevalence and Progression Rate of Diabetic Retinopathy in Type 2 Diabetes Patients in Correlation with the Duration of DiabetesExperimental and Clinical Endocrinology & Diabetes, 2017
- Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinomaJournal of Clinical Laboratory Analysis, 2016
- Association of C(-106)T Polymorphism in Aldose Reductase Gene with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes MellitusChinese Medical Sciences Journal, 2014
- Association of RAGE (p.Gly82Ser) and MnSOD (p.Val16Ala) polymorphisms with diabetic retinopathy in T2DM patients from north IndiaDiabetes Research and Clinical Practice, 2014
- Association of the Receptor for Advanced Glycation End Products Gene Polymorphisms and Circulating RAGE Levels with Diabetic Retinopathy in the Chinese PopulationJournal of Diabetes Research, 2013
- Lack of association between Gly82Ser, 1704G/T and 2184A/G of RAGE gene polymorphisms and retinopathy susceptibility in Malaysian diabetic patientsGenetics and Molecular Research, 2012
- An association between vascular endothelial growth factor gene promoter polymorphisms and diabetic retinopathyGraefe's Archive for Clinical and Experimental Ophthalmology, 2007
- Diabetic retinopathy in Euro-Brazilian type 2 diabetic patients: relationship with polymorphisms in the aldose reductase, the plasminogen activator inhibitor-1 and the methylenetetrahydrofolate reductase genesDiabetes Research and Clinical Practice, 2003